Top

Published in:

01-11-2006

Prognosis of Breast Cancer After Supraclavicular Lymph Node Metastasis: Not a Distant Metastasis

Authors: Shin-Cheh Chen, MD, Hsien-Kun Chang, MD, Yung-Chang Lin, MD, Wai-Man Leung, MD, Chien-Sheng Tsai, MD, Yun-Chung Cheung, MD, Swei Hsueh, MD, Lai-Chu See, PhD, Miin-Fu Chen, MD, FACS

Published in: Annals of Surgical Oncology | Issue 11/2006

Abstract

Background

We performed this study to analyze the survival of breast cancer patients with isolated supraclavicular lymph node metastasis (SLNM) and assess whether SLNM is distant metastasis or not.

Methods

Sixty-three patients who developed an isolated SLNM among 3170 primary breast cancer patients between 1990 and 1999 were enrolled. The survival after SLNM was compared with that of 151 patients who developed local recurrences and 599 who had distant metastasis and was analyzed according to different levels and numbers of positive axillary nodes.

Results

Thirty-five of the 63 patients died during a median follow-up of 58.3 months. The 5-year overall survival (OS) rates after SLNM, local relapse, and distant metastasis were 33.6%, 34.9%, and 9.1%, respectively. The 5-year OS for patients with involved nodes confined to axillary level I was 74.4%, which was significantly better than that for involved nodes in level II or III or SLNM (49.2%, 52.8%, and 33.6%, respectively; P < .0001). For one to three positive axillary nodes, the 5-year OS was 83.2%, which was significantly better than that for four to nine positive nodes, more than nine positive nodes, and SLNM (62.6%, 42.3%, and 33.6%, respectively). There was no significant difference between SLNM and more than nine positive nodes. Surgical removal of the supraclavicular nodes was a significantly better prognostic factor for OS after SLNM (P = .0327).

Conclusions

The 5-year OS after supraclavicular nodal metastosis, local relapse, and distant metastasis were 33.6%, 34.9%, and 9.1%, respectively. Good neck control either by surgery or chemotherapy achieved better survival.

Fentiman IS, Lavelle MA, Caplan D, et al. The significance of supraclavicular recurrence of breast cancer. Cancer 1986;57:908–10CrossRefPubMed

Halverson KJ, Perez CA, Kuske RR, et al. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1992;23:285–91PubMed

Debois JM. The significance of a supraclavicular node metastasis in patients with breast cancer. Strahlenther Onkol 1997;173:1–12PubMedCrossRef

Mc Kinna F, Gothard L, Ashley S, et al. Lymphatic relapse in women with early breast cancer: a difficult management problem. Eur J Cancer 1999;35:1065–9CrossRef

Fodor J, Tóth J, Major T, et al. Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation. Int J Radiat Oncol Biol Phys 1999;44:281–7CrossRefPubMed

Kiricuta IC, Willner J, Kölbl O, et al. The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients. Int J Radiat Oncol Biol Phys 1993;28:387–93

Signletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628–36CrossRef

Chen SC, Chen MF, Hwang TL, et al. Prediction of supraclavicular lymph node metastasis in breast carcinoma. Int J Radiat Oncol Biol Phys 2002;52:614–9CrossRefPubMed

Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastasis: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 2001;19:628–33PubMed

10.

Olivotto IA, Chua B, Allan SJ, et al. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol 2003;21:851–4CrossRefPubMed

11.

Clemons M, Danson S, Hamilton T, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 2001;27:67–82CrossRefPubMed

12.

Voss M, Schneider JW, Apffelstaedt J. Axillary lymph node involvement in stage III breast cancer: treatment implications. J Surg Oncol 1999;(Suppl 71):162–6

13.

Axelsson CK, Rank F, Blichert-Toft M. Impact of axillary dissection on staging and regional control in breast tumor < or = 10 mm: the DBCG experience. Acta Oncol 2000;39:283–9CrossRefPubMed

14.

Tocchi A, Mazzoni G, Bettelli E, et al. Impact of axillary level I and II lymph node dissection on the therapy of stage I and II breast cancer. Panminerva Med 2001;43:103–7PubMed

15.

Picrquin B, Mazeron JJ, Glaubiger D. Conservative treatment of breast cancer in Europe. Radiother Oncol 1986;6:187–98

16.

Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:1689–700PubMed

17.

Ellis H, Colborn GL, Skandalakis JE. Surgical embryology and anatomy of the breast and its related anatomic structures. Surg Clin North Am 1993;73:611–32PubMed

18.

Skandalakis LJ, Vohman MD, Skandalakis JE, et al. The axillary lymph nodes in radical and modified radical mastectomy. Am Surg 1979;45:552–5PubMed

19.

Veronesi U, Luini A, Galimberti V, et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990;16:127–33PubMed

20.

Nathanson SD, Wachna DL, Gilman D, et al. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 2001;8:837–43CrossRefPubMed

21.

Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917–24CrossRefPubMed

22.

Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181–7CrossRefPubMed

23.

Tienhoven GV, Borger JH, Passchier DH, et al. The prognostic significance of the axillary apex biopsy in clinically operable breast cancer. Eur J Cancer 1995;31:1965–8CrossRef

24.

Cheng JC, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1–3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol 2002;52:980–8CrossRef

25.

Jatoi I, Hilsenbeck SG, Clark GM, et al. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999;17:2334–40PubMed

26.

Canavese G, Catturich A, Vecchio C, et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 1998;24:104–9CrossRefPubMed

27.

Zurrida S, Morabito A, Galimberti V, et al. Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int J Oncol 1999;15:475–80PubMed

28.

Clemons M, Hamilton T, Goss P. Does treatment at the time of locoregional failure of breast cancer alter prognosis? Cancer Treat Rev 2001;27:83–97CrossRefPubMed

29.

Lê MG, Arriagada R, Spielmann M, et al. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma. Cancer 2002;94:2813–20CrossRefPubMed

30.

Pergolizzi S, Settineri N, Russi EG, et al. Supraclavicular lymph node metastases (SLM) from breast cancer as only site of distant disease: has radiotherapy any role? Anticancer Res 1997;17:2303–8PubMed

31.

Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002;132:620–7CrossRefPubMed

32.

Vicini FA, Kestin L, Huang R, et al. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 2003;97:910–9CrossRefPubMed

33.

Noguchi M. Does regional treatment improve the survival in patients with operable breast cancer? Br Cancer Res Treat 2002;76:269–82CrossRef

34.

Rauschecker H, Clarke M, Gatzemeier W, et al. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev 2001:4

Title: Prognosis of Breast Cancer After Supraclavicular Lymph Node Metastasis: Not a Distant Metastasis
Authors: Shin-Cheh Chen, MD
Hsien-Kun Chang, MD
Yung-Chang Lin, MD
Wai-Man Leung, MD
Chien-Sheng Tsai, MD
Yun-Chung Cheung, MD
Swei Hsueh, MD
Lai-Chu See, PhD
Miin-Fu Chen, MD, FACS
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 11/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-006-9012-1

At a glance: The STEP trials

Springer Medicine

Prognosis of Breast Cancer After Supraclavicular Lymph Node Metastasis: Not a Distant Metastasis

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2006

The Prognostic Effect of Micrometastases in Previously Staged Lymph Node Negative (N0) Colorectal Carcinoma: A Meta-analysis

Assessing the State of Surgical Oncology: The Future Is Now

Accuracy of the Combination of Mammography and Sonography in Predicting Tumor Response in Breast Cancer Patients After Neoadjuvant Chemotherapy

Surgical Procedures After Neoadjuvant Chemotherapy in Operable Breast Cancer: Results of the GEPARDUO Trial

Lymph Node Status in Patients with Submucosal Gastric Cancer

eRFA: Excision Followed by RFA—a New Technique to Improve Local Control in Breast Cancer